Hospitals and outpatient facilities purchased $100 billion worth of drugs in the 340B discount program in 2025, an almost 23% increase from the year prior as regulators look to reform the program. The latest data from the Health and Services Administration shows 340B spending has more than doubled since 2021. The vast majority of purchases — almost $80 billion — were made by disproportionate share hospitals last year. Regulators said pricey specialty drugs that treat complex, chronic conditions were also making up a larger portion of 340B spending. Although specialty drugs constituted about 38% of purchases, they accounted for almost 62% of total spending last year, according to the data.
Read the full article: 340B Spending Ballooned to $100B in 2025, Federal Data Shows //
Source: https://www.healthcaredive.com/news/340b-spending-ballooned-100-billion-2025-federal-data-shows/825395/